“…DAVID‐based analysis revealed that pathways enriched in Ishikawa cells following Tsc‐sEV treatment (Figure 3C, Table 2, Table S11) include protein translation and localization [22,23,117,118] (module 1 and 3) (translation initiation/elongation factors, ribosomal subunits), immune regulation [24,119] (module 2), antioxidant activity [120,121] (module 4, 8), cell‐matrix adhesion and laminin binding [101] (module 12, 16), NAD metabolism [122] (module 18), cadherin binding (module 20) [90,91]; processes that are dynamically regulated at the site of implantation. On the other hand, pathways underrepresented in recipient cells include DNA replication and elongation (module 5) [123,124], carbon metabolism (TCA cycle) (module 11, 17), actin cytoskeleton organisation (module 14, 15), and oxidoreductase activity (module 19) (Figure 3D, Table S11).…”